메뉴 건너뛰기




Volumn 36, Issue 11, 2014, Pages 1555-1561

TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck

Author keywords

cetuximab; cisplatin; cisplatin 5 fluorouracil (TPF) chemotherapy; head and neck cancer; induction docetaxel; radiotherapy

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; TAXOID;

EID: 84933506109     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23506     Document Type: Article
Times cited : (14)

References (41)
  • 1
    • 0023575637 scopus 로고
    • Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial
    • Fu KK, Phillips TL, Silverberg IJ, et al., Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410-1418.
    • (1987) J Clin Oncol , vol.5 , pp. 1410-1418
    • Fu, K.K.1    Phillips, T.L.2    Silverberg, I.J.3
  • 2
    • 0037208591 scopus 로고    scopus 로고
    • An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemotherapy in patients with unresectable squamous cell head and neck cancer
    • Adelstein DJ, Li Y, Adams GL, et al., An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92-98.
    • (2003) J Clin Oncol , vol.21 , pp. 92-98
    • Adelstein, D.J.1    Li, Y.2    Adams, G.L.3
  • 3
    • 51449093748 scopus 로고    scopus 로고
    • Concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: Phase I-II clinical study
    • Strojan P, Karner K, Smid L, et al., Concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study. Int J Radiat Oncol Biol Phys 2008; 72: 365-372.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 365-372
    • Strojan, P.1    Karner, K.2    Smid, L.3
  • 4
    • 80051781309 scopus 로고    scopus 로고
    • Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV local advanced HNSCC: Results of a GORTEC randomized trial
    • Bourhis J, Lapeyre M, Tortochaux J, et al., Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV local advanced HNSCC: results of a GORTEC randomized trial. Radiother Oncol 2011; 100: 56-61.
    • (2011) Radiother Oncol , vol.100 , pp. 56-61
    • Bourhis, J.1    Lapeyre, M.2    Tortochaux, J.3
  • 5
    • 35548966042 scopus 로고    scopus 로고
    • Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
    • Vermorken JB, Remenar E, van Herpen C, et al., Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357: 1695-1704.
    • (2007) N Engl J Med , vol.357 , pp. 1695-1704
    • Vermorken, J.B.1    Remenar, E.2    Van Herpen, C.3
  • 6
    • 35548972994 scopus 로고    scopus 로고
    • Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
    • Posner MR, Hershock DM, Blajman CR, et al., Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007; 357: 1705-1715.
    • (2007) N Engl J Med , vol.357 , pp. 1705-1715
    • Posner, M.R.1    Hershock, D.M.2    Blajman, C.R.3
  • 7
    • 32144433159 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    • Bonner JA, Harari PM, Giralt J, et al., Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578.
    • (2006) N Engl J Med , vol.354 , pp. 567-578
    • Bonner, J.A.1    Harari, P.M.2    Giralt, J.3
  • 8
    • 77956266565 scopus 로고    scopus 로고
    • A review of the clinical evidence for intensity-modulated radiotherapy
    • Radiotherapy Development Board
    • Staffurth J,; Radiotherapy Development Board. A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 2010; 22: 643-657.
    • (2010) Clin Oncol (R Coll Radiol) , vol.22 , pp. 643-657
    • Staffurth, J.1
  • 9
    • 84939216393 scopus 로고    scopus 로고
    • A study on conventional IMRT and RapidArc treatment planning techniques for head and neck cancers
    • Kumar S, Sriram P, Saranya K, Bhuvaneswari N, Vivekanandan N,. A study on conventional IMRT and RapidArc treatment planning techniques for head and neck cancers. Int J Radiat Oncol Biol Phys 2010; 78 (Suppl): S836-S837.
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , pp. S836-S837
    • Kumar, S.1    Sriram, P.2    Saranya, K.3    Bhuvaneswari, N.4    Vivekanandan, N.5
  • 10
    • 26444450999 scopus 로고    scopus 로고
    • ConPas: A 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT
    • Wiggenraad R, Mast M, van Santvoort J, Hoogendoorn M, Struikmans H,. ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 2005; 181: 673-682.
    • (2005) Strahlenther Onkol , vol.181 , pp. 673-682
    • Wiggenraad, R.1    Mast, M.2    Van Santvoort, J.3    Hoogendoorn, M.4    Struikmans, H.5
  • 11
    • 39049165254 scopus 로고    scopus 로고
    • Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
    • Bernier J, Bonner J, Vermorken JB, et al., Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 2008; 19: 142-149.
    • (2008) Ann Oncol , vol.19 , pp. 142-149
    • Bernier, J.1    Bonner, J.2    Vermorken, J.B.3
  • 12
    • 80855132770 scopus 로고    scopus 로고
    • In inverted papillomas HPV more likely represents incidental colonization than an etiological factor
    • Jenko K, Kocjan B, Zidar N, et al., In inverted papillomas HPV more likely represents incidental colonization than an etiological factor. Virchows Arch 2011; 459: 529-538.
    • (2011) Virchows Arch , vol.459 , pp. 529-538
    • Jenko, K.1    Kocjan, B.2    Zidar, N.3
  • 13
    • 0035970795 scopus 로고    scopus 로고
    • Sample size tables for exact single-stage phase II designs
    • A'Hern RP,. Sample size tables for exact single-stage phase II designs. Stat Med 2001; 20: 859-866.
    • (2001) Stat Med , vol.20 , pp. 859-866
    • A'Hern, R.P.1
  • 14
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 15
    • 0017365573 scopus 로고
    • Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
    • Peto R, Pike MC, Armitage P, et al., Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
    • (1977) Br J Cancer , vol.35 , pp. 1-39
    • Peto, R.1    Pike, M.C.2    Armitage, P.3
  • 16
    • 84865317847 scopus 로고    scopus 로고
    • DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    • (abstr 5500)
    • Cohen EEW, Karrison T, Kocherginsky M, et al., DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol 2012; 30 (Suppl 15): 356s (abstr 5500).
    • (2012) J Clin Oncol , vol.30 , pp. 356s
    • Cohen, E.E.W.1    Karrison, T.2    Kocherginsky, M.3
  • 17
    • 84875267472 scopus 로고    scopus 로고
    • Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial
    • Haddad R, O'Neill A, Rabinowits G, et al., Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 2013; 14: 257-264.
    • (2013) Lancet Oncol , vol.14 , pp. 257-264
    • Haddad, R.1    O'Neill, A.2    Rabinowits, G.3
  • 19
    • 84875264233 scopus 로고    scopus 로고
    • Chemoradiotherapy vs. Total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma
    • Strojan P, Haigentz M Jr, Bradford CR, et al., Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. Oral Oncol 2012; 49: 283-286.
    • (2012) Oral Oncol , vol.49 , pp. 283-286
    • Strojan, P.1    Haigentz, Jr.M.2    Bradford, C.R.3
  • 20
    • 84873825096 scopus 로고    scopus 로고
    • Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: Results from a randomized, phase II prospective trial
    • Mesía R, Rueda A, Vera R, et al., Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Ann Oncol 2013; 24: 448-453.
    • (2013) Ann Oncol , vol.24 , pp. 448-453
    • Mesía, R.1    Rueda, A.2    Vera, R.3
  • 21
    • 73249143536 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
    • Bonner JA, Harari PM, Giralt J, et al., Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010; 11: 21-28.
    • (2010) Lancet Oncol , vol.11 , pp. 21-28
    • Bonner, J.A.1    Harari, P.M.2    Giralt, J.3
  • 22
    • 51649085865 scopus 로고    scopus 로고
    • Platinum-based chemotherapy plus cetuximab in head and neck cancer
    • Vermorken JB, Mesia R, Rivera F, et al., Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008; 359: 1116-1127.
    • (2008) N Engl J Med , vol.359 , pp. 1116-1127
    • Vermorken, J.B.1    Mesia, R.2    Rivera, F.3
  • 23
    • 78249251774 scopus 로고    scopus 로고
    • Head and neck cancer: Proteomic advances and biomarker achievements
    • Rezende TM, de Souza Freire M, Franco OL,. Head and neck cancer: proteomic advances and biomarker achievements. Cancer 2010; 116: 4914-4925.
    • (2010) Cancer , vol.116 , pp. 4914-4925
    • Rezende, T.M.1    De Souza Freire, M.2    Franco, O.L.3
  • 24
    • 79952027751 scopus 로고    scopus 로고
    • Image cytometric nuclear texture features in inoperable head and neck cancer: A pilot study
    • Strojan-Flezar M, Lavrencak J, Zganec M, Strojan P,. Image cytometric nuclear texture features in inoperable head and neck cancer: a pilot study. Radiol Oncol 2011; 45: 40-45.
    • (2011) Radiol Oncol , vol.45 , pp. 40-45
    • Strojan-Flezar, M.1    Lavrencak, J.2    Zganec, M.3    Strojan, P.4
  • 25
    • 34548487155 scopus 로고    scopus 로고
    • High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history
    • O'Neil BH, Allen R, Spigel DR, et al., High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history. J Clin Oncol 2007; 25: 3644-3648.
    • (2007) J Clin Oncol , vol.25 , pp. 3644-3648
    • O'Neil, B.H.1    Allen, R.2    Spigel, D.R.3
  • 26
    • 77953053076 scopus 로고    scopus 로고
    • Managing cetuximab hypersensitivity-infusion reactions: Incidence, risk factors, prevention, and retreatment
    • George TJ Jr, Laplant KD, Walden EO, et al., Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment. J Support Oncol 2010; 8: 72-77.
    • (2010) J Support Oncol , vol.8 , pp. 72-77
    • George, Jr.T.J.1    Laplant, K.D.2    Walden, E.O.3
  • 27
    • 79960517479 scopus 로고    scopus 로고
    • Incidence and predictors of cetuximab hypersensitivity reactions in a North Carolina academic medical center
    • Hansen NL, Chandiramani DV, Morse MA, Wei D, Hedrick NE, Hansen RA,. Incidence and predictors of cetuximab hypersensitivity reactions in a North Carolina academic medical center. J Oncol Pharm Pract 2011; 17: 125-130.
    • (2011) J Oncol Pharm Pract , vol.17 , pp. 125-130
    • Hansen, N.L.1    Chandiramani, D.V.2    Morse, M.A.3    Wei, D.4    Hedrick, N.E.5    Hansen, R.A.6
  • 28
    • 33644971314 scopus 로고    scopus 로고
    • Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality paradigm
    • Pfister DG, Su YB, Kraus DH, et al., Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol 2006; 24: 1072-1078.
    • (2006) J Clin Oncol , vol.24 , pp. 1072-1078
    • Pfister, D.G.1    Su, Y.B.2    Kraus, D.H.3
  • 29
    • 84860448909 scopus 로고    scopus 로고
    • A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma
    • Ma BB, Kam MK, Leung SF, et al., A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma. Ann Oncol 2012; 23: 1287-1292.
    • (2012) Ann Oncol , vol.23 , pp. 1287-1292
    • Ma, B.B.1    Kam, M.K.2    Leung, S.F.3
  • 30
    • 79951861341 scopus 로고    scopus 로고
    • Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer
    • Argiris A, Heron DE, Smith RP, et al., Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. J Clin Oncol 2010; 28: 5294-5300.
    • (2010) J Clin Oncol , vol.28 , pp. 5294-5300
    • Argiris, A.1    Heron, D.E.2    Smith, R.P.3
  • 31
    • 77958486627 scopus 로고    scopus 로고
    • Phase i trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck
    • Kuhnt T, Sandner A, Wendt T, et al., Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Ann Oncol 2010; 21: 2284-2289.
    • (2010) Ann Oncol , vol.21 , pp. 2284-2289
    • Kuhnt, T.1    Sandner, A.2    Wendt, T.3
  • 32
    • 84862817048 scopus 로고    scopus 로고
    • Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: A randomized study
    • Wang ZH, Zhang SZ, Zhang ZY, et al., Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study. Laryngoscope 2012; 122: 291-298.
    • (2012) Laryngoscope , vol.122 , pp. 291-298
    • Wang, Z.H.1    Zhang, S.Z.2    Zhang, Z.Y.3
  • 33
    • 79151484611 scopus 로고    scopus 로고
    • Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial
    • Nutting CM, Morden JP, Harrington KJ, et al., Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127-136.
    • (2011) Lancet Oncol , vol.12 , pp. 127-136
    • Nutting, C.M.1    Morden, J.P.2    Harrington, K.J.3
  • 34
    • 84894256986 scopus 로고    scopus 로고
    • Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: An evidence-based review
    • [Epub ahead of print]
    • Paleri V, Roe JW, Strojan P, et al., Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck 2013 [Epub ahead of print].
    • (2013) Head Neck
    • Paleri, V.1    Roe, J.W.2    Strojan, P.3
  • 35
    • 81855184870 scopus 로고    scopus 로고
    • Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck
    • Levy AR, Johnston KM, Sambrook J, et al., Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck. Curr Med Res Opin 2011; 27: 2253-2259.
    • (2011) Curr Med Res Opin , vol.27 , pp. 2253-2259
    • Levy, A.R.1    Johnston, K.M.2    Sambrook, J.3
  • 36
    • 44449161951 scopus 로고    scopus 로고
    • Locoregionally advanced head and neck cancer treated with primary radiotherapy: A comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment
    • Caudell JJ, Sawrie SM, Spencer SA, et al., Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys 2008; 71: 676-681.
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , pp. 676-681
    • Caudell, J.J.1    Sawrie, S.M.2    Spencer, S.A.3
  • 37
    • 80255134559 scopus 로고    scopus 로고
    • Concurrent cisplatin and radiotherapy versus cetuximab and radiation for locally advanced head-and-neck cancer
    • Koutcher L, Sherman E, Fury M, et al., Concurrent cisplatin and radiotherapy versus cetuximab and radiation for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011; 81: 915-922.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 915-922
    • Koutcher, L.1    Sherman, E.2    Fury, M.3
  • 38
    • 78651368497 scopus 로고    scopus 로고
    • Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)
    • Walsh L, Gillham C, Dunne M, et al., Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC). Radiother Oncol 2011; 98: 38-41.
    • (2011) Radiother Oncol , vol.98 , pp. 38-41
    • Walsh, L.1    Gillham, C.2    Dunne, M.3
  • 39
    • 79961128389 scopus 로고    scopus 로고
    • Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT
    • Studer G, Brown M, Salgueiro EB, et al., Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT. Int J Radiat Oncol Biol Phys 2011; 81: 110-117.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 110-117
    • Studer, G.1    Brown, M.2    Salgueiro, E.B.3
  • 40
    • 69949157387 scopus 로고    scopus 로고
    • Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro
    • Zhang N, Erjala K, Kulmala J, et al., Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro. Radiother Oncol 2009; 92: 388-392.
    • (2009) Radiother Oncol , vol.92 , pp. 388-392
    • Zhang, N.1    Erjala, K.2    Kulmala, J.3
  • 41
    • 80053368876 scopus 로고    scopus 로고
    • A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinoma (HNC)
    • (abstr 5500)
    • Ang KK, Zhang QE, Rosenthal DI, et al., A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinoma (HNC). J Clin Oncol 2011; 29 (Suppl): 360s (abstr 5500).
    • (2011) J Clin Oncol , vol.29 , pp. 360s
    • Ang, K.K.1    Zhang, Q.E.2    Rosenthal, D.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.